Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
J Steroid Biochem Mol Biol ; 164: 199-204, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-26709139

RESUMO

INTRODUCTION: Due to the high prevalence of vitamin D deficiency, strategies are needed to improve vitamin D status. Food components can affect vitamin D metabolism and have to be considered when estimating the efficacy of vitamin D supplements. 7-dehydrocholesterol (7-DHC) occurs naturally in food, but its impact on vitamin D metabolism has not yet been examined. METHODS: Three groups of male C57BL/6 mice (n=12 per group) were placed on a diet that contained 0, 2.5 or 5mg 7-DHC per kg diet over a period of 6 weeks. Vitamin D and other sterols in the serum, skin, liver and kidney were quantified by LC-MS/MS. The relative mRNA abundance of hepatic genes encoding vitamin D hydroxylation enzymes and transporters was analyzed by real-time RT-PCR. RESULTS: We found a substantial dose-dependent increase of non-hydroxylated vitamin D3 in the liver and kidney of mice fed a diet containing 7-DHC. The vitamin D3 content in the liver was 2.80±0.61pmol/g, 7.34±4.28pmol/g and 12.9±3.58pmol/g in groups that received 0, 2.5 and 5mg/kg 7-DHC, respectively. In the kidney, the vitamin D3 content of these groups was 1.78±1.17pmol/g, 3.55±1.06 and 6.36±2.29pmol/g, respectively. The serum and tissue concentrations of 25-hydroxyvitamin D3 (25(OH)D3) remained unaffected by 7-DHC. The relative mRNA data provided no plausible mechanism for the observed effects of 7-DHC on vitamin D3. All groups of mice had similar concentrations of cholesterol, desmosterol and 7-DHC in their serum and tissues. CONCLUSION: The current findings provide the first evidence that dietary 7-DHC seems to affect vitamin D metabolism. The underlying mechanism remains elusive and needs further investigation.


Assuntos
Colecalciferol/metabolismo , Desidrocolesteróis/farmacologia , Rim/metabolismo , Fígado/metabolismo , Provitaminas/farmacologia , Administração Oral , Ração Animal/análise , Animais , Calcifediol/análise , Calcifediol/sangue , Calcifediol/metabolismo , Colecalciferol/análise , Colecalciferol/sangue , Colesterol/análise , Colesterol/sangue , Colesterol/metabolismo , Desidrocolesteróis/administração & dosagem , Suplementos Nutricionais/análise , Masculino , Camundongos Endogâmicos C57BL , Provitaminas/administração & dosagem , Triglicerídeos/análise , Triglicerídeos/sangue , Triglicerídeos/metabolismo
2.
Free Radic Biol Med ; 70: 129-40, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-24561580

RESUMO

Ultraviolet radiation is the main cause of skin cancers, and melanoma is the most serious form of tumor. There is no therapy for advanced-stage melanoma and its metastasis because of their high resistance to various anticancer therapies. Human skin is an important metabolic organ in which occurs photoinduced synthesis of vitamin D3 from 7-dehydrocholesterol (7-DHC). 7-DHC, the precursor of cholesterol biosynthesis, is highly reactive and easily modifiable to produce 7-DHC-derived compounds. The intracellular levels of 7-DHC or its derivatives can have deleterious effects on cellular functionality and viability. In this study we evaluated the effects on melanoma cell lines of 7-DHC as such and for this aim we used much care to minimize 7-DHC modifications. We found that from 12 to 72 h of treatment 82-86% of 7-DHC entered the cells, and the levels of 7-DHC-derived compounds were not significant. Simultaneously, reactive oxygen species production was significantly increased already after 2h. After 24 h and up to 72 h, 7-DHC-treated melanoma cells showed a reduction in cell growth and viability. The cytotoxic effect of 7-DHC was associated with an increase in Bax levels, decrease in Bcl-2/Bax ratio, reduction of mitochondrial membrane potential, increase in apoptosis-inducing factor levels, unchanged caspase-3 activity, and absence of cleavage of PARP-1. These findings could explain the mechanism through which 7-DHC exerts its cytotoxic effects. This is the first report in which the biological effects found in melanoma cells are mainly attributable to 7-DHC as such.


Assuntos
Apoptose/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Desidrocolesteróis/efeitos adversos , Melanoma/tratamento farmacológico , Apoptose/efeitos da radiação , Proliferação de Células/efeitos da radiação , Desidrocolesteróis/administração & dosagem , Humanos , Melanoma/patologia , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Potencial da Membrana Mitocondrial/efeitos da radiação , Estadiamento de Neoplasias , Pele/efeitos dos fármacos , Pele/patologia , Pele/efeitos da radiação , Raios Ultravioleta
3.
Biochem Biophys Res Commun ; 358(2): 495-9, 2007 Jun 29.
Artigo em Inglês | MEDLINE | ID: mdl-17493586

RESUMO

The requirement of membrane cholesterol in maintaining ligand binding activity of the hippocampal serotonin(1A) receptor has previously been demonstrated. In order to test the stringency of the requirement of cholesterol, we depleted cholesterol from native hippocampal membranes followed by replenishment with 7-dehydrocholesterol. The latter sterol is an immediate biosynthetic precursor of cholesterol differing only in a double bond at the 7th position in the sterol ring. Our results show, for the first time, that replenishment with 7-dehydrocholesterol does not restore ligand binding activity of the serotonin(1A) receptor, in spite of recovery of the overall membrane order. The requirement for restoration of ligand binding activity therefore is more stringent than the requirement for the recovery of overall membrane order. These novel results have potential implications in understanding the interaction of membrane lipids with this important neuronal receptor under pathogenic conditions such as the Smith-Lemli-Opitz syndrome.


Assuntos
Colesterol/administração & dosagem , Desidrocolesteróis/administração & dosagem , Hipocampo/metabolismo , Receptor 5-HT1A de Serotonina/efeitos dos fármacos , Receptor 5-HT1A de Serotonina/metabolismo , Síndrome de Smith-Lemli-Opitz/metabolismo , Animais , Células Cultivadas , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Hipocampo/efeitos dos fármacos , Ligantes , Camundongos , Ligação Proteica/efeitos dos fármacos
4.
J Nutr Sci Vitaminol (Tokyo) ; 38(1): 15-25, 1992 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-1629783

RESUMO

Metabolism of orally administered ergosterol (Erg) and 7-dehydrocholesterol (7-DHC) in rats and their vitamin D biological activity were investigated. Most of orally administered Erg and 7-DHC were excreted in feces and the remaining sterols were absorbed through intestine. The absorbed sterols were not transported in skin as the intact forms but metabolized into brassicasterol and cholesterol, respectively, within 25 h. Neither increment of intestinal calcium absorption nor plasma calcium concentrations were observed by oral administration of Erg and 7-DHC to vitamin D-deficient rats. Therefore, we have concluded that orally administered Erg and 7-DHC have no vitamin D biological activity.


Assuntos
Desidrocolesteróis/farmacocinética , Ergosterol/farmacocinética , Vitamina D/fisiologia , Administração Oral , Animais , Cálcio/metabolismo , Cromatografia Líquida de Alta Pressão , Desidrocolesteróis/administração & dosagem , Ergosterol/administração & dosagem , Cromatografia Gasosa-Espectrometria de Massas , Absorção Intestinal , Masculino , Ratos , Ratos Endogâmicos , Distribuição Tecidual , Trítio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA